Roche Quarterly Sales Held Back by Blockbuster Eye Drug
Roche Holding’s results showed a slower-than-expected recovery for eye blockbuster Vabysmo as investors look to a key new drug to power growth ahead.
Roche Holding’s results showed a slower-than-expected recovery for eye blockbuster Vabysmo as investors look to a key new drug to power growth ahead.
China’s sovereign bonds are rallying once again as economic weakness, sliding stocks and expectations for greater monetary policy support revive demand for fixed-income assets.
SBI Funds Management is planning its first technology-focused fund for private firms, people familiar with the matter said, as India’s largest asset manager follows rivals in bulking up in the fast-growing alternative investment fund industry.
With AI spending skyrocketing, investors are looking for Alphabet Inc.’s earnings to show strong growth in its cloud-computing business, which would demonstrate a clear return on the company’s investments.
Investment funds and other speculators boosted their net-long positions in European gas by the most since the first week of the Iran war, signaling a strong conviction that prices still have room to rise as the conflict darkens the supply outlook ahead of winter.
The term TACO — “Trump always chickens out” — has become a popular, if not always reliable, method to forecast the next turn from the mercurial American president, who’s now leading a new fight against Iran that few see as winnable.
It took a Chinese artificial-intelligence tool to protect an American company from an American AI attack.